Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Mitzi M. Gonzales, Sudarshan Krishnamurthy, Valentina R. Garbarino, et al.
Mechanisms of Ageing and Development (2021) Vol. 200, pp. 111589-111589
Open Access | Times Cited: 24

Showing 24 citing articles:

Cellular senescence: a key therapeutic target in aging and diseases
Lei Zhang, Louise E. Pitcher, Matthew J. Yousefzadeh, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 311
Biological aging processes underlying cognitive decline and neurodegenerative disease
Mitzi M. Gonzales, Valentina R. Garbarino, Erin Pollet, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 10
Open Access | Times Cited: 180
An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease
Victor Lau, Leanne M. Ramer, Marie‐Ève Tremblay
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 95
Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s disease
Krithi Irmady, Caryn Hale, Rizwana Qadri, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome
Breno S. Diniz, Benoit H. Mulsant, Charles F. Reynolds, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2219678-e2219678
Open Access | Times Cited: 19
Circulating biomarkers of inflammaging and Alzheimer’s disease to track age-related trajectories of dementia: Can we develop a clinically relevant composite combination?
Angela Marie Abbatecola, Angelica Giuliani, Leonardo Biscetti, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102257-102257
Closed Access | Times Cited: 4
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease
Miranda E. Orr, Valentina R. Garbarino, Juan Pablo Palavicini, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 4
Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities
Hannah R. Hudson, Xuehan Sun, Miranda E. Orr
Neurotherapeutics (2025) Vol. 22, Iss. 3, pp. e00519-e00519
Open Access
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease
Valentina R. Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Neurotherapeutics (2025), pp. e00591-e00591
Open Access
Pharmacological interventions in human aging
Michael Petr, Frida Matiyevskaya, Brenna Osborne, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102213-102213
Closed Access | Times Cited: 3
Role of Exosomes in Parkinson’s and Alzheimer’s Diseases
Himanshu Sharma, Siddhant Jai Tyagi, Phool Chandra, et al.
(2024), pp. 147-182
Closed Access | Times Cited: 3
Geroscience-Centric Perspective for Geriatric Psychiatry: Integrating Aging Biology With Geriatric Mental Health Research
Breno S. Diniz, Johanna Seitz‐Holland, Raghav Sehgal, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 32, Iss. 1, pp. 1-16
Open Access | Times Cited: 7
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment
Miranda E. Orr, Eithan Kotkowski, Paulino Ramirez, et al.
GeroScience (2023) Vol. 46, Iss. 1, pp. 665-682
Open Access | Times Cited: 7
Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer’s Disease: Findings from Clinical Trials
Xi Chen, Karen Walton, Henry Brodaty, et al.
Journal of Alzheimer s Disease (2024), pp. 1-23
Closed Access | Times Cited: 2
Role of Cytoskeletal Elements in Regulation of Synaptic Functions: Implications Toward Alzheimer’s Disease and Phytochemicals-Based Interventions
Harkomal Verma, Sharanjot Kaur, Sukhchain Kaur, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8320-8343
Closed Access | Times Cited: 2
The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging
Meriel Owen, Nandita Bose, Laura Nisenbaum, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 6
New Trends in Aging Drug Discovery
Bellinda Benhamú, Mar Martín‐Fontecha, Henar Vázquez‐Villa, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2006-2006
Open Access | Times Cited: 9
The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
Zoë J. Williams, Lyndah Chow, Steven P. Dow, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1
Involvement of astrocyte senescence in Alzheimer's disease
Ferit Tüzer, Claudio Torres
Current Opinion in Neurobiology (2022) Vol. 76, pp. 102594-102594
Closed Access | Times Cited: 5
Senolytic drugs: Beyond the promise and the hype
Diana Jurk, João F. Passos
Mechanisms of Ageing and Development (2022) Vol. 202, pp. 111631-111631
Open Access | Times Cited: 3
Molecular Interplay of Oxidative Stress and Gut Microbiome in Aging
Ahamed Basha Abdul Bari, Madhan Krishnan, Shyamaladevi Babu
(2024), pp. 143-159
Closed Access
Current Research About Senotherapeutics
Gabriel Bennett
(2024), pp. 21-40
Closed Access
DNA nanoparticles targeting FOXO4 selectively eliminate cigarette smoke-induced senescent lung fibroblasts
YAOPIN HAN, Yixing Wu, Binfeng He, et al.
Nanoscale Advances (2023) Vol. 5, Iss. 21, pp. 5965-5973
Open Access | Times Cited: 1
The Glial Aging & Senescence Hypothesis of Late-onset Alzheimer’s
Victor Lau, Leanne M. Ramer, Marie‐Ève Tremblay
(2022)
Open Access | Times Cited: 1
Targeting senescent cells to treat age-related diseases
Miranda E. Orr, Michiel Tent
(2022)
Closed Access
Page 1

Scroll to top